These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38115009)

  • 1. Stereotactic radiosurgery of brain metastases: a retrospective study.
    Gruber I; Weidner K; Treutwein M; Koelbl O
    Radiat Oncol; 2023 Dec; 18(1):202. PubMed ID: 38115009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionated stereotactic radiotherapy of brain metastases: results of a retrospective study.
    Gruber I; Stark P; Weidner K; Treutwein M; Koelbl O
    Radiat Oncol; 2023 May; 18(1):85. PubMed ID: 37217924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
    Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
    Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery.
    Chang EL; Selek U; Hassenbusch SJ; Maor MH; Allen PK; Mahajan A; Sawaya R; Woo SY
    Neurosurgery; 2005 May; 56(5):936-45; discussion 936-45. PubMed ID: 15854241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
    Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
    J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients.
    Lehrer EJ; Ahluwalia MS; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Jones BM; Green S; Sheehan JP; Trifiletti DM
    J Neurosurg; 2023 May; 138(5):1178-1187. PubMed ID: 36115055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases.
    Sneed PK; Chan JW; Ma L; Braunstein SE; Theodosopoulos PV; Fogh SE; Nakamura JL; Boreta L; Raleigh DR; Ziemer BP; Morin O; Hervey-Jumper SL; McDermott MW
    J Neurosurg; 2023 Jan; 138(1):104-112. PubMed ID: 35594891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases.
    Lwu S; Goetz P; Monsalves E; Aryaee M; Ebinu J; Laperriere N; Menard C; Chung C; Millar BA; Kulkarni AV; Bernstein M; Zadeh G
    Oncol Rep; 2013 Feb; 29(2):407-12. PubMed ID: 23151681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
    Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
    J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiosurgery for intraventricular brain metastases.
    Farnia B; Voong KR; Brown PD; Allen PK; Guha-Thakurta N; Prabhu SS; Rao G; Wang Q; Zhao Z; Mahajan A
    J Neurosurg; 2014 Dec; 121 Suppl():26-34. PubMed ID: 25434934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma.
    Powell JW; Chung CT; Shah HR; Canute GW; Hodge CJ; Bassano DA; Liu L; Mitchell L; Hahn SS
    J Neurosurg; 2008 Dec; 109 Suppl():122-8. PubMed ID: 19123898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
    Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
    J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
    Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
    Neurosurgery; 2002 Sep; 51(3):656-65; discussion 665-7. PubMed ID: 12188943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
    Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
    Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.